Pavittar Pharmaceuticals

Chandigarh, India Founded: 2021 • Age: 5 yrs
Manufacturer of pharmaceutical tablets, injections, syrups, and contract services.
Annual revenue $243,994 Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 6 Services tracked
Competitors 9 Brand Intelligence

About Pavittar Pharmaceuticals

Pavittar Pharmaceuticals is a company based in Chandigarh (India) founded in 2021. It operates as a B2B and Franchise Model. The company has 1 employees as of March 31, 2023. Pavittar Pharmaceuticals offers products and services including PCD Pharma Franchise, Pharmaceutical Tablets, Pharmaceutical Injections, Pharmaceutical Syrup and Suspension, and Pharmaceutical Capsules. Pavittar Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Chandigarh, India
  • Employees 1 as on 31 Mar, 2023
  • Sectors
    Industrial Goods & Manufacturing
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Pavittar Pharmaceuticals Private Limited
  • Jurisdiction Chandigarh, Chandigarh, India
Operational Areas
Industrial Goods & Manufacturing → Contract & Custom Manufacturing Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $243.99 K (USD)
    96.95
    as on Mar 31, 2023
  • Net Profit
    $1.06 K (USD)
    10.32
    as on Mar 31, 2023
  • EBITDA
    $20.61 K (USD)
    184.81
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pavittar Pharmaceuticals

Pavittar Pharmaceuticals offers a comprehensive portfolio of products and services, including PCD Pharma Franchise, Pharmaceutical Tablets, Pharmaceutical Injections, Pharmaceutical Syrup and Suspension, and Pharmaceutical Capsules.

Product name locked
Category locked
Primary

Provides franchise opportunities for pharmaceutical distribution networks

Product name locked
Category locked
Locked

Manufactures various tablets for medical treatments and health

Product name locked
Category locked
Locked

Produces injections for therapeutic and preventive care

Product name locked
Category locked
Locked

Offers syrups and suspensions for easy medication intake

Product name locked
Category locked
Locked

Creates capsules for targeted drug delivery systems

Product name locked
Category locked
Locked

Delivers third-party manufacturing for custom pharmaceutical needs

Funding Insights of Pavittar Pharmaceuticals

Premium access

Detailed funding history for Pavittar Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Pavittar Pharmaceuticals

Investments
Premium access

Investment portfolio details for Pavittar Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Pavittar Pharmaceuticals

Premium access

Detailed financials for Pavittar Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Pavittar Pharmaceuticals Comparisons

Pavittar Pharmaceuticals Primary company
Description
Manufacturer of pharmaceutical tablets, injections, syrups, ...
Location
Chandigarh, India
Founded Year
2021
Annual Revenue
$243.99 K (USD)
Net Profit
$1.06 K (USD)
EBITDA
$20.61 K (USD)
Employees
1
As of 2023
Premium access

Peer comparison for Pavittar Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Pavittar Pharmaceuticals

Pavittar Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Pavittar Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Pavittar Pharmaceuticals

Premium access

Complete news archive for Pavittar Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavittar Pharmaceuticals

Pavittar Pharmaceuticals was founded in 2021.

Pavittar Pharmaceuticals is headquartered in Chandigarh, India.

As of Mar 31, 2023, the latest employee count at Pavittar Pharmaceuticals is 1.

Annual revenue of Pavittar Pharmaceuticals is $243.99K as on Mar 31, 2023.

Pavittar Pharmaceuticals Private Limited, located in Chandigarh, India, operates as a manufacturer and trader of various pharmaceutical products including tablets, injections, syrups, capsules, and suspensions. They provide PCD Pharma Franchise and third-party manufacturing services, catering to wholesalers and distributors through contract manufacturing. The company focuses on quality pharmaceutical solutions and business segments like franchisee services, serving the healthcare sector with reliable supply chains.

Pavittar Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Pavittar Pharmaceuticals offers PCD Pharma Franchise, Pharmaceutical Tablets, Pharmaceutical Injections, Pharmaceutical Syrup and Suspension, and 2 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available